Brooks & Leathem, [7] conducted a retrospective study spanning 24 years, involving 373 breast cancer patients, of which 293 (79%) had tumours positive for binding of HPA and 80 (21%) had tumours negative for HPA binding. This evidence concerns the gene HPSE and breast cancer.